Last SFr.108.50 CHF
Change Today 0.00 / 0.00%
Volume 0.0
ATLN On Other Exchanges
Symbol
Exchange
OTC US
Xetra
SIX Swiss Ex
OTC US
As of 11:43 AM 08/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael Jacobi

Director and Chairman of Finance & Audit Committee, Actelion Ltd.
AgeTotal Calculated CompensationThis person is connected to 30 board members in 5 different organizations across 6 different industries.

See Board Relationships
61SFr.222,034

Background*

Dr. Michael Jacobi has been an Independent Corporate Consultant Since 2007. Dr. Jacobi served as the Chief Financial Officer of Ciba Holding, Inc. from 1997 to March 2007. He was responsible for Treasury, Mergers and Acquisitions (M&A), Investor Relations, Control and Information Management. He became Group Controller of Ciba-Geigy in 1990 where he had been responsible for CIBA Specialty Chemicals Holding Inc.'s overall corporate financial accounting and reporting. In ...

Read Full Background

Corporate Headquarters*

Gewerberstrasse 16
Allschwil, Basel-Landschaft 4123

Switzerland

Phone: 41 61 565 65 65
Fax: 41 61 565 65 00

Board Members Memberships*

Director
Director
2003-Present
Non-Executive Director and Chairman of Audit Committee
2007-Present
Director and Chairman of Audit Committee
2009-Present
Director and Chairman of Finance & Audit Committee

Education*

Unknown/Other Education
Universität St. Gallen
Doctorate 1979
Universität St. Gallen
Unknown/Other Education
Harvard Business School
Unknown/Other Education
University of Washington
Doctorate 1979
University of St.Gallen , Washington D.C

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash CompensationSFr.203,500
Total Calculated CompensationSFr.222,034
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATLN:VX SFr.108.50 CHF 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jean-Jacques Bienaimé Chief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$868.8K
Martine A. Rothblatt Ph.D., J.D., MBAFounder, Chairman and Chief Executive Officer
United Therapeutics Corporation
$992.7K
Marc M.P. de Garidel Chairman, Chief Executive Officer and Member of Strategic Committee
Ipsen S.A.
€1.4M
Jörg-Thomas Dierks Chief Executive Officer
Meda AB
kr2.1M
Timo Lappalainen M.Sc. (Ind. Eng.)Chairman of the Executive Management Board, Chief Executive Officer and President
Orion Oyj
€1.4M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACTELION LTD-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.